Related Experiment Video
Updated: Feb 12, 2026

Gastrointestinal Motility Monitor GIMM
Published on: December 1, 2010
[Recommendation for gastroprotection in gastrointestinal bleeding prevention]
Insights
Gastrointestinal bleeding affects 1 in 1,000 people, often linked to NSAIDs and aspirin. Prevention strategies are crucial due to persistent mortality rates, emphasizing careful patient selection and medication management.
Area of Science:
- Gastroenterology
- Pharmacology
- Internal Medicine
Background:
- Gastrointestinal (GI) bleeding affects approximately 1 in 1,000 individuals annually.
- Drug use, particularly non-steroidal anti-inflammatory drugs (NSAIDs) and low-dose acetyl-salicylic acid (aspirin), accounts for over 65% of GI bleeding episodes.
- The mortality rate within one month of a GI bleeding event remains high at 10-12%, showing no significant decrease over the past decade.
Purpose of the Study:
- To highlight the significant incidence and mortality associated with gastrointestinal bleeding.
- To identify the primary drug classes contributing to gastrointestinal bleeding.
- To underscore the critical importance of gastrointestinal bleeding prevention strategies.
Main Methods:
- Review of epidemiological data on gastrointestinal bleeding incidence.
- Analysis of drug-related causes of gastrointestinal bleeding.
- Examination of mortality trends and established preventive measures.
Main Results:
- NSAIDs and low-dose aspirin are the most frequent culprits in drug-associated GI bleeding.
- Mortality rates for GI bleeding have remained stagnant at 10-12% in the short term.
- Effective prevention relies on patient selection, judicious drug choice, and dose optimization.
Conclusions:
- Gastrointestinal bleeding prevention is paramount due to its significant incidence and persistent mortality.
- Key preventive measures include careful patient selection, appropriate drug selection, using the lowest effective doses of ulcerogenic medications, and employing gastric acid inhibitors.
Abstract:
Incidence of gastrointestinal bleeding in most populations is about 1 per 1,000 inhabitants. More than 65% of all bleeding episodes are associated with drug use. The most often involved are non-steroidal antiinflammatory drugs and low doses of acetyl-salicylic acid. The mortality within the first month after the bleeding episode is about 10–12%, and has not significantly changed in the last decade. Therefore, bleeding prevention is of major importance. Appropriate selection of patients, proper drug choice, application of lowest efficient doses of potentially ulcerogenic drugs, and use of drugs that inhibit gastric acid secretion remain cornerstone preventive measures of gastrointestinal bleeding.
Related Concept Videos
Bleeding in Fresh Concrete
Bleeding can cause several issues in the concrete structure. Sometimes, the rising water gets trapped beneath large aggregate...
Anatomy of the Gastrointestinal System
Here's a detailed walkthrough of this complex system:
Cancer Prevention
Some...
Gastrointestinal Motility Disorders
Histology of the Gastrointestinal (GI) Tract
The mucosa is sometimes called a mucous membrane due to its mucus-secreting features. This membrane is composed of epithelium, which directly interacts with ingested substances, and the lamina propria, a layer...
Prevention of Further Absorption of Poison

